Context Therapeutics Inc. (CNTX) Misses Q2 EPS by 11c

Context Therapeutics Inc. (NASDAQ: CNTX) reported Q2 EPS of ($0.31), $0.11 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Context Therapeutics Inc. (CNTX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Freedom Broker Starts Unity Bancorp (UNTY) at Hold
• Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT